ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/14/2022
Back to search
Official data from USPTO
ACROTECH BIOPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ACROTECH BIOPHARMA
ST13
US500000087983952Class
5
Filing
87983952
Registration
6502623
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
73
Latest update
09/14/2022
Trademark type
Word
Nice classes
5
Filing date
01/05/2018
Registration date
09/28/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/28/2021
Last transaction
02/09/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/01/2019
First use in commerce
03/01/2019
Drawing code
4
Owner type
03
Owner location
EAST WINDSOR, NJ
Examiner
ROSSMAN, WILLIAM
Law office
L90
Current location
TMEG LAW OFFICE 109
Holders and representatives
Holders
ACROTECH BIOPHARMA INC.
Acrotech Biopharma LLC
Representatives
Sandra J Wunderlich Tucker Ellis LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Prescription based pharmaceutical preparations for use in connection with humans for the prevention and treatment of oncological and rare diseasesdisorders and conditions
Publications
History of USPTO decisions and trademark events.
73 publications found
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
08/12/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/02/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/07/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/07/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/07/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/07/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/07/2022
ES7R
TEAS SECTION 7 REQUEST RECEIVED
03/08/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/09/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/09/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/09/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/09/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/28/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/24/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/22/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/28/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/27/2021
DPCC
DIVISIONAL PROCESSING COMPLETE
07/27/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/20/2021
INCD
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
05/20/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/26/2021
IUAF
USE AMENDMENT FILED
03/29/2021
DRRR
DIVISIONAL REQUEST RECEIVED
03/29/2021
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
03/29/2021
EISU
TEAS STATEMENT OF USE RECEIVED
03/29/2021
EX5G
SOU EXTENSION 5 GRANTED
03/22/2021
EXT5
SOU EXTENSION 5 FILED
03/22/2021
EEXT
SOU TEAS EXTENSION RECEIVED
03/22/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/22/2020
EX4G
SOU EXTENSION 4 GRANTED
09/18/2020
EXT4
SOU EXTENSION 4 FILED
09/18/2020
EEXT
SOU TEAS EXTENSION RECEIVED
09/18/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/10/2020
EX3G
SOU EXTENSION 3 GRANTED
03/07/2020
EXT3
SOU EXTENSION 3 FILED
03/07/2020
EEXT
SOU TEAS EXTENSION RECEIVED
03/07/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/03/2019
EX2G
SOU EXTENSION 2 GRANTED
10/01/2019
EXT2
SOU EXTENSION 2 FILED
10/01/2019
EEXT
SOU TEAS EXTENSION RECEIVED
10/01/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/15/2019
EX1G
SOU EXTENSION 1 GRANTED
03/13/2019
EXT1
SOU EXTENSION 1 FILED
03/13/2019
EEXT
SOU TEAS EXTENSION RECEIVED
03/13/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/09/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/14/2018
PUBO
PUBLISHED FOR OPPOSITION
08/14/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/25/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/30/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
06/30/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/30/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
06/30/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/30/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
06/22/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/22/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
06/22/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/22/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/25/2018
GNFR
FINAL REFUSAL E-MAILED
05/25/2018
CNFR
FINAL REFUSAL WRITTEN
05/25/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/03/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/02/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/02/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/18/2018
GNRT
NON-FINAL ACTION E-MAILED
04/18/2018
CNRT
NON-FINAL ACTION WRITTEN
04/18/2018
DOCK
ASSIGNED TO EXAMINER
04/16/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/30/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/30/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/19/2018
NWAP
NEW APPLICATION ENTERED
01/09/2018
Continuous trademark protection
Get notified about every new filing that threatens ACROTECH BIOPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.